In a landmark announcement, the NHS has introduced a beacon of hope for individuals susceptible to type 1 diabetes. Teplizumab, an innovative medication, is now able to delay the disease’s onset for an average of three years, focusing on the autoimmune process impacting the pancreas. This breakthrough provides vital time for young patients, allowing them to manage their health more effectively before the disease fully manifests.
In a thrilling matchup against the Buffalo Bills, Patrick Herbert prepares for his NFL debut,…
Three individuals lost their lives while four others sustained injuries in a shooting at a…
Virat Kohli became only the second batter after Sachin Tendulkar to complete 15,000 ODI runs.…
In Nepal, heavy rainfall has caused devastating floods and landslides, resulting in 21 lives lost…